On October 12, 2022, the FDA announced a shortage of Adderall and Adderall IR. These shortages have exacerbated withdrawal symptoms and left patients struggling to manage their ADHD by rationing their medication. Understanding how...
On October 12, the FDA reported a shortage of amphetamine aspartate, more commonly known as Adderall. This was one of seven shortages reported by the FDA since the beginning of the month, and it joins...
In the United States and worldwide, hospitals are experiencing a shortage of critical iodinated contrast media — also called contrast dye — a nontoxic, contrasting agent that radiologists...
FDA recently proposed a rule to provide greater assurance that supply chain participants are sufficiently qualified to distribute prescription drugs, strengthening the pharmaceutical supply chain.
The...
Most pregnant and postpartum women with opioid use disorder (OUD) in US jails do not receive medication that is standard of care, a JAMA Network Open study found.
The cross-sectional study surveyed...
Premier and 11 top health systems recently acquired a minority stake in Exela Holdings, the holding company of Exela Pharma Sciences, to combat drug shortages in the US.
Participating Premier...
A recent study found that the biopharmaceutical industry will be negatively effected by the COVID-19 pandemic and policymakers should make changes to avoid the impact.
For more coronavirus...
HHS recently announced that it will expand pharmaceutical manufacturing in the US to produce medicines needed during the COVID-19 pandemic and boost capacity for producing finished generic drugs.
For...
Premier Inc recently found that drug shortages to treat cardiovascular conditions have increased due to the COVID-19 pandemic, according to a press release.
For more coronavirus updates, visit...
Merck estimates that the novel coronavirus outbreak will decrease the company’s 2020 revenues by over $2 billion as social distancing and other precautions impact business, according to the...
Eli Lilly and Company recently announced that it partnered with the National Institutes of Allergy and Infectious Diseases (NIAID) to study baricitinib as part of NIAID’s Adaptive COVID-19...
The American Society of Health-System Pharmacists (ASHP) recently called on the Trump Administration to address shortages of supportive ventilator drugs as COVID-19 continues to infect more...
Vizient recently announced it has sent recommendations to the White House Coronavirus Task Force and FDA to improve access for two potential COVID-19 drugs: chloroquine and hydroxychloroquine.
For...
As the FDA closely monitors the coronavirus supply chain, it has uncovered a drug shortage related to a site affected by the coronavirus, or COVID-19, according to a recent statement from Stephen M....
Reliance on just a select few pharmaceutical companies to carry the fight against the growing public health threat that is antimicrobial resistance could be what is holding back real...
